Science · 2018
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragón L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L.
Show affiliations
- Routy B — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Le Chatelier E — MGP MetaGénoPolis, INRA, Université Paris-Saclay, Jouy-en-Josas, France.
- Derosa L — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Duong CPM — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Alou MT — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Daillère R — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Fluckiger A — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Messaoudene M — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Rauber C — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Roberti MP — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Fidelle M — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Flament C — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Poirier-Colame V — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Opolon P — Gustave Roussy, Laboratoire de Pathologie Expérimentale, 94800 Villejuif, France.
- Klein C — Centre de Recherche des Cordeliers, INSERM, Université Paris Descartes, Sorbonne Paris Cité, UMRS 1138, Université Pierre et Marie Curie Université Paris 06, Sorbonne Universités, Paris, France.
- Iribarren K — Metabolomics and Cell Biology Platforms, GRCC, Villejuif, France.
- Mondragón L — Metabolomics and Cell Biology Platforms, GRCC, Villejuif, France.
- Jacquelot N — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Qu B — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Ferrere G — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Clémenson C — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Mezquita L — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Masip JR — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Naltet C — Thoracic Oncology Department-CIC1425/CLIP2 Paris-Nord, Hospital Bichat-Claude Bernard, AP-HP, Université Paris-Diderot, Paris, France.
- Brosseau S — Thoracic Oncology Department-CIC1425/CLIP2 Paris-Nord, Hospital Bichat-Claude Bernard, AP-HP, Université Paris-Diderot, Paris, France.
- Kaderbhai C — Department of Medical Oncology, Center GF Leclerc, Dijon, France.
- Richard C — Department of Medical Oncology, Center GF Leclerc, Dijon, France.
- Rizvi H — Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Levenez F — MGP MetaGénoPolis, INRA, Université Paris-Saclay, Jouy-en-Josas, France.
- Galleron N — MGP MetaGénoPolis, INRA, Université Paris-Saclay, Jouy-en-Josas, France.
- Quinquis B — MGP MetaGénoPolis, INRA, Université Paris-Saclay, Jouy-en-Josas, France.
- Pons N — MGP MetaGénoPolis, INRA, Université Paris-Saclay, Jouy-en-Josas, France.
- Ryffel B — Molecular Immunology and Embryology, UMR 7355, CNRS, University of Orleans, Orléans, France.
- Minard-Colin V — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Gonin P — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Soria JC — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Deutsch E — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Loriot Y — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Ghiringhelli F — Department of Medical Oncology, Center GF Leclerc, Dijon, France.
- Zalcman G — Thoracic Oncology Department-CIC1425/CLIP2 Paris-Nord, Hospital Bichat-Claude Bernard, AP-HP, Université Paris-Diderot, Paris, France.
- Goldwasser F — Paris Descartes University, Sorbonne Paris Cité, Paris, France.
- Escudier B — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Hellmann MD — Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Eggermont A — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Raoult D — URMITE, Aix Marseille Université, UM63, CNRS 7278, IRD 198, INSERM 1095, IHU-Méditerranée Infection, 13005 Marseille, France.
- Albiges L — Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Kroemer G — Metabolomics and Cell Biology Platforms, GRCC, Villejuif, France. laurence.zitvogel@gustaveroussy.fr kroemer@orange.fr.
- Zitvogel L — Gustave Roussy Cancer Campus (GRCC), Villejuif, France. laurence.zitvogel@gustaveroussy.fr kroemer@orange.fr.
29 read3 want to readRigor 3.0Novelty 3.4Impact 3.0Reprod. 2.4
Most-cited papers citing this
- Nat Med · 2026 · cited by 3
- Nature · 2026 · cited by 3
- Cell Res · 2026 · cited by 2
- Cytokine Growth Factor Rev · 2026 · cited by 2
- Ann Surg Oncol · 2026 · cited by 2
Log in to like, log, and share thoughts on this paper.
Discussion
Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.
0
0
0
0
0
0
0
0
0
0